The U.S. House of Representatives is once again attempting, under the Controlled Substances Act(CSA), to deprive an executive agency from its powers to reschedule and deschedule marijuana.
On July 15, the House Appropriations Subcommittee on Commerce, Justice, Science and Related Agencies (CJS), approved a bill that prohibits the Department of Justice from reclassifying cannabis to Schedule I, which places it alongside heroin, LSD, and ecstasy.
It is important to note that the word “you” means “you”. 154-page legislationThe full committee will now consider the bill, which provides almost $77 billion of discretionary funding, including $37.3 Billion to the DOJ. According to a committee subcommittee, the DOJ’s allocation would include $2.8 billion for direct appropriations to be given to the Drug Enforcement Administration. Summary.
Cannabis is not mentioned in the CJS summary. It covers law enforcement, trade, and space exploration. The members of the Subcommittee did not address cannabis during their meeting. The hourly markup Before voting 9-6 to approve the legislation, the Bill was voted on.
It is not difficult to understand the Cannabis Rescheduling Provision:
SEC. 607. The funds made available or appropriated by this Act cannot be used to redistribute marijuana, as defined in the Controlled Substances Act section 102 (21 U.S.C. The funds appropriated or otherwise made available by this Act may not be used to reschedule marijuana (as such term is defined in section 102 of the Controlled Substances Act (2 U.S.C. 812).
Pam Bondi is currently the U.S. Attorney general. unilateral authority The Attorney General has the authority to regulate, reschedule, or decontrol substances under the CSA. Delegation of authority is a tradition This is what you should do: The following are some of the ways to get in touch with us The DEA has existed since its inception in 1973.
Rescheduling hearings by the DEA is a problem, say lawyers.
Congress has the power to reschedule and deschedule marijuana through laws such as Marijuana Opportunity, Reinvestment and Expungement.You can find out more about it here.) Act, which passed twice in the U.S. House under the sponsorship of Rep. Jerry Nadler, D-N.Y., in previous congresses.
In this Congress, Ohio Republican Reps. Max Miller and Dave Joyce, as well as Nevada Democratic Rep. Dina T. Titus. You may also like: The STATES 2.0 Act (Tenth Amendment Through Entrusting States) also aims to legalize marijuana at the federal level by removing cannabis from the CSA.
It is ironic that this legislative effort comes at a time when the House CJS legislation aims to exclude the executive from the equation of cannabis rescheduling. This, despite an earlier Biden proposal rule for cannabis to be moved to Schedule II. Play continues.
Smart Approaches to Marijuana – a cannabis prohibitionist group – praised subcommittee approval of provisions related to marijuana.
House CJS Appropriations bills just passed. SAM-backed provision block federal reclassification of marijuana, and restore DOJ’s power to go after the media. [sic] Even in states with legal marijuana, dispensaries can be found near schools,” said the group. Write on X. This is an important victory for the public’s health and safety.
The patchwork legalization of cannabis in the United States has led to a variety of buffer zones. Many states prohibit dispensaries being within 1,000 feet from schools. This is consistent with U.S. laws that increase penalties for doing business within this radius.
The CJS Bill maintains a funding restriction of 11 years that prohibits the DOJ to use tax dollars for prosecutions against medical cannabis users and licensed medical cannabis businesses. Congress has included this rider every fiscal year starting in FY2015. The Blocks The DOJ is prohibited from interfering in the implementation of “their laws” that allow the use, distribution or possession of medical marijuana.
Following President Donald Trump’s request for a budget in June, the subcommittee took the decision to retain the CJS riders in FY2026. Call for its repeal. This decision is made by Congress.
Apart from cannabis-related provisions the CJS bill also supports many other Trump administration directives. This includes preventing DOJ funds from being used to fund abortions, terminating diversity, equity, and inclusion programs (DEI), as well as maintaining the prohibitions of funding COVID vaccination and mask mandates.
This legislation also aims to reduce illicit drug availability and combat transnational organised crime by funding Organized Crime Drug Enforcement Task Forces at $400 million or 27% less than the FY2025 level.
The House Appropriations Committee included cannabis rescheduling in its budget. Bill FY2025 It was finally defeated last year.
The U.S. House of Representatives is once again attempting strip an executive branch agency from its powers delegated to reschedule and deschedule marijuana under the Controlled Substances Act.
On July 15, the House Appropriations Subcommittee on Commerce, Justice, Science and Related Agencies (CJS), approved a bill that prohibits the Department of Justice from using money to remove cannabis from Schedule I, which places it alongside heroin, LSD, and ecstasy.
It is important to note that the word “you” means “you”. 154-page legislationThe full committee will now consider the bill, which provides almost $77 billion of discretionary funding, including $37.3 Billion to the DOJ. According to a committee subcommittee, the DOJ’s allocation would include $2.8 billion for direct appropriations to be given to the Drug Enforcement Administration. Summary.
The summary of the CJS does not mention cannabis. The members of the Subcommittee did not address cannabis during their meeting. The hourly markup Before voting 9-6 to approve the legislation, the Bill was voted on.
The cannabis rescheduling provisions is very clear:
SEC. 607. The funds made available or appropriated by this Act cannot be used to redistribute marijuana, as defined in the Controlled Substances Act section 102 (21 U.S.C. The funds appropriated or otherwise made available by this Act may not be used to reschedule marijuana (as such term is defined in section 102 of the Controlled Substances Act (2 U.S.C. 812).
Pam Bondi is currently the U.S. Attorney general. unilateral authority Although the Attorney General is empowered to schedule, reschedule, or decontrol substances under the CSA Delegation of authority is a tradition This is what you should do: The following are some of the ways to get in touch with us The DEA was established in 1973.
Rescheduling hearings by the DEA is a problem, say lawyers.
Congress has the power to reschedule and deschedule marijuana through laws such as Marijuana Opportunity, Reinvestment and Expungement.You can find out more about it here.The ) Act was passed by the U.S. House twice under the sponsorship and leadership of Rep. Jerry Nadler (D-N.Y.), in previous Congresses.
In this Congress, Ohio Republican Reps. Max Miller and Dave Joyce, as well as Nevada Democratic Rep. Dina T. Titus. You can also read about the advantages of using Tenth Amendment Through Entrusting States 2.0 Act, also aims at federally legalizing cannabis by removing the CSA.
It is ironic that this legislative effort comes at a time when the House CJS legislation aims to exclude the executive branch in the equation of cannabis rescheduling. This, despite an earlier Biden rule proposal to place cannabis on Schedule III. Play on!.
Smart Approaches to Marijuana, a group that advocates the prohibition of cannabis, praised the approval by the Subcommittee for the provisions relating to the drug.
The House CJS Appropriations Bill just passed, with SAM-backed clauses blocking federal rescheduling and giving DOJ the power to pursue medial. [sic] “More marijuana dispensaries are being built near schools in states where it is legal,” says the group. Write on X. This is an important victory for the public’s health and safety.
The patchwork legalization of cannabis in the United States has led to a variety of buffer zones. Many states prohibit dispensaries being within 1,000 feet from schools. This is consistent with U.S. laws that increase penalties for doing business within this radius.
The CJS Bill maintains a funding restriction of 11 years that prohibits the DOJ to use tax dollars for prosecutions against medical cannabis users and licensed medical cannabis businesses. Congress has included this rider every fiscal year starting in FY2015. The Blocks The DOJ is prohibited from interfering in the implementation of “their laws” that allow the use, distribution or possession of medical marijuana.
Following President Donald Trump’s request for a budget in June, the subcommittee took the decision to retain the CJS riders in FY2026. Call for its repeal. This decision is made by Congress.
The CJS Appropriations Bill supports a number of Trump Administration mandates. These include preventing DOJ funding to be used for abortion, ending Diversity, Equity and Inclusion (DEI), and maintaining prohibitions against funding COVID vaccine mandates and mask requirements.
It also aims to reduce illicit drug availability and combat transnational organised crime by funding Organized Crime Drug Enforcement Task Forces for $400 million, which is 27% lower than FY2025’s enacted amount.
The House Appropriations Committee included cannabis rescheduling in its budget. Bill FY2025 It was finally defeated last year.
Cannabis Law Resources in Poland
Discover essential legal information about the cultivation of cannabis, its sale, and regulations governing medical products in Poland. You can use these resources to learn about the requirements for certification, permissions and compliance.
-
Polish News Registration and Interests of Cannabis Businesses
-
Permissions for Cannabis Sales in Poland
-
Authorization for Importing or Manufacturing Medical Products
-
Permission for Manufacturing or Importing Medical Products
-
Certificate of Good Manufacturing Practices (GMP)
-
Registration of Medical Products in Poland